Barcode Five Rights System



Use Barcode to prevent medication errors



ADERS ® is a barcode point of care, (BPOC), solution

Request Info











Practical Compliance Solutions, Corp. helps care facilities reduce risk at the patient's bedside. Our five rights barcode solution is the easiest to implement. Our barcode point of care system can help prevent medication errors in hospitals, long term care facilities, and assisted living communities.

ADERS ® is our barcode solution for the healthcare industry. It helps eliminate medication errors by allowing caregivers to scan NDC barcodes at the patient's bedside, verifying right patient, right drug, right time, right dose, and right route of administration. For more information click the products menu or send us a web request from our Contact menu. Ask for a DEMO CD. It is the full product that is licensed for an evaluation period.

We are offering a 30 day no-obligation free trial of the ADERS ® software. Care facilities can easily determine if ADERS ® is right for them by using the software as a pilot for a single unit or ward. Click here to download a Microsoft Project plan showing how you can implement a five rights point of care barcode pilot in less than a week. If you Don't own MS Project 2003, then here is a PDF copy just to see.... Download Adobe PDF Data Sheet

View a PowerPoint Presentation of ADERS ®.





Current Patient Safety and Drug Safety Updates from the FDA


FDA Press Releases RSS Feed

Coronavirus (COVID-19) Update: FDA Issues New Policy on Dry Heat for Reuse of Certain Respirators
Wed, 25 Nov 2020 14:39:16 EST

  The FDA issued guidance on the use of dry heat for bioburden reduction to help support the single-user reuse of certain particulate filtering facepiece respirators (FFRs), such as N95 respirators, by health care personnel when there is a limited supply during the COVID-19 public health emergency.

Coronavirus (COVID-19) Update: November 24, 2020
Tue, 24 Nov 2020 18:13:56 EST

  Coronavirus (COVID-19) Update

FDA Approves First Drug to Treat Rare Metabolic Disorder
Mon, 23 Nov 2020 18:48:40 EST

  Today, the FDA approved the first treatment for primary hyperoxaluria type 1 (PH1), a rare genetic disorder which causes recurrent kidney stones and loss of kidney function.

Coronavirus (COVID-19) Update: November 23, 2020
Mon, 23 Nov 2020 17:57:16 EST

  Coronavirus (COVID-19) Update, November 23, 2020

FDA Expands Approval of Influenza Treatment to Post-Exposure Prevention
Mon, 23 Nov 2020 12:59:39 EST

  Today, the FDA expanded the approved indication for Xofluza (baloxavir marboxil) to include post-exposure prevention of influenza (flu) for patients 12 years of age and older after contact with an individual who has the flu.

Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19
Sat, 21 Nov 2020 19:27:13 EST

  Today, the FDA issued an emergency use authorization for two monoclonal antibodies to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients who are at high risk for progressing to severe COVID-19.

Coronavirus (COVID-19) Update: November 20, 2020
Fri, 20 Nov 2020 18:48:02 EST

  Coronavirus (COVID-19) Update

FDA Approves First Treatment for Hutchinson-Gilford Progeria Syndrome and Some Progeroid Laminopathies
Fri, 20 Nov 2020 17:30:43 EST

  Today, the U.S. Food and Drug Administration approved Zokinvy (lonafarnib) capsules to reduce the risk of death due to Hutchinson-Gilford Progeria Syndrome and for the treatment of certain processing-deficient progeroid laminopathies in patients one year of age and older.

Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccine Candidate
Fri, 20 Nov 2020 16:54:25 EST

  FDA has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10, 2020 to discuss Pfizer and BioNTech’s emergency use authorization request for a COVID-19 vaccine.

Coronavirus (COVID-19) Update: FDA Authorizes Drug Combination for Treatment of COVID-19
Thu, 19 Nov 2020 16:26:45 EST

  Today, the FDA issued an emergency use authorization for the drug baricitinib, in combination with remdesivir, for the treatment of COVID-19 in hospitalized adults and pediatric patients 2+ years requiring supplemental oxygen, invasive mechanical ventilation, or ECMO.

FDA Releases New Outbreak Investigation Table
Wed, 18 Nov 2020 15:14:26 EST

  FDA releases new tool to communicate foodborne illness outbreak information frequently and as soon as the FDA begins an outbreak investigation.

Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Test for Self-Testing at Home
Tue, 17 Nov 2020 21:29:11 EST

  The FDA issued an emergency use authorization for the first COVID-19 diagnostic test that allows for self-collection and testing at home and provides test results in 30 minutes or less.

Coronavirus (COVID-19) Update: November 17, 2020
Tue, 17 Nov 2020 17:26:54 EST

  Coronavirus (COVID-19) Update

COVID-19 Update: FDA’s Ongoing Commitment to Transparency for COVID-19 EUAs
Tue, 17 Nov 2020 09:46:48 EST

  FDA is committed to transparency around the EUA process

Coronavirus (COVID-19) Update: November 16, 2020
Mon, 16 Nov 2020 18:02:24 EST

  Coronavirus (COVID-19) Update

FDA Approves First Intratumoral Injection to Treat Non-Metastatic Mast Cell Tumors in Dogs
Mon, 16 Nov 2020 13:02:49 EST

  FDA approves first intratumoral injection to treat dogs with non-metastatic, skin-based (cutaneous) mast cell tumors (MCTs). The FDA is also approving Stelfonta to treat non-metastatic MCTs located under the dog’s skin (subcutaneous), in particular areas of a dog’s leg.

Coronavirus (COVID-19) Update: November 13, 2020
Fri, 13 Nov 2020 17:35:49 EST

  Coronavirus (COVID-19) Update

Coronavirus (COVID-19) Update: November 12, 2020
Thu, 12 Nov 2020 18:13:41 EST

  Coronavirus (COVID-19) Update

Coronavirus (COVID-19) Update: November 10, 2020
Tue, 10 Nov 2020 17:43:26 EST

  Coronavirus (COVID-19) Update

FDA Encourages Manufacturers to Clearly Declare All Uses of Sesame in Ingredient List on Food Labels
Tue, 10 Nov 2020 10:22:35 EST

  FDA has issued a draft guidance encouraging food manufacturers to voluntarily declare sesame in the ingredient list on food labels. While most products declare sesame as an ingredient, there are times when sesame is not required to be declared, such as in flavors and spices.

Food and Drugs Administration--Recalls/Safety Alerts

Vegpro International Issues a Recall of Fresh Attitude Baby Spinach Because of Potential Salmonella Health Risk
Fri, 27 Nov 2020 00:00:00 EST

  Vegpro International of Sherrington, QC CAN is recalling Fresh Attitude baby spinach (5oz and 11oz) with Best before dates of Dec 4th (for 11oz) and Dec 4th & 5th (for the 5oz), because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal

Prairie Farms Issues Allergy Alert on Undeclared Egg in Chocolate Milk Gallons
Wed, 25 Nov 2020 14:16:00 EST

  Prairie Farms has issued a limited voluntary recall of its Prairie Farms Premium Flavored Chocolate Milk gallons and Prairie Farms 1% Lowfat Chocolate Milk gallons (Best by Date: Dec. 4, 2020) that were not labeled for an egg allergen that may be present. People who have an allergy or severe sensit

Shenandoah Growers Inc Issues a Limited, Voluntary Recall of Certain Imported Organic Basil Because of Potential Health Risk
Tue, 24 Nov 2020 16:47:00 EST

  Shenandoah Growers, Inc (Harrisonburg, VA) out of an abundance of caution, has issued a limited, voluntary recall of approximately 15,000 units in select packages, due to a possible health risk from Cyclospora.

Hy-Vee Voluntarily Recalls Two Short Cuts Vegetable Mix Products Because of Possible Health Risk
Tue, 24 Nov 2020 00:00:00 EST

  Hy-Vee, Inc., based in West Des Moines, Iowa, is voluntarily recalling two of its Hy-Vee Short Cuts vegetable mix products across its eight-state region (IL, IA, KS, MN, MO, NE, SD, and WI) due to possible contamination with Listeria monocytogenes. The potential for contamination was discovered duri

Riverside Natural Foods LTD. Issues Allergy Alert on Undeclared Almond in "Good & Gather Banana Chocolate Chip Date & Nut Bar"
Mon, 23 Nov 2020 11:17:00 EST

  Riverside Natural Foods, of Vaughan, ON is voluntarily recalling its 8 ounce packages of " Good & Gather Banana Chocolate Chip Date & Nut Bar " because they were improperly labelled and may contain undeclared almonds. The product is labelled to may contain tree nuts; however, people who have allergi

Allergy Alert Issued for Undeclared Shrimp in Mislabeled Popcorn Chicken from 26 Whole Foods Market Stores
Mon, 23 Nov 2020 00:00:00 EST

  Whole Foods Market is voluntarily recalling packaged popcorn chicken with sweet chili sauce across 26 stores in Northern California and Reno, Nevada.

Fusion Health and Vitality Issues Voluntary Nationwide Recall of Core Essential Nutrients and Immune Boost Sublingual Vitamin D3 Due to the Unapproved Use of a Food Additive and Unapproved Marketing Statements
Sun, 22 Nov 2020 11:46:00 EST

  Fusion Health and Vitality LLC is voluntarily recalling all 2020 Lots of CORE essential nutrients and Immune Boost Sublingual Vitamin D3. CORE has been found to contain an unapproved food additive, hordenine HCl, rendering it adulterated. Immune Boost Labeling was found to contain statements that

Dole Fresh Vegetables Announces Limited Recall of Organic Romaine Hearts
Sat, 21 Nov 2020 18:46:00 EST

  Dole Fresh Vegetables, Inc. is voluntarily recalling a limited number of cases of organic romaine hearts. The products being recalled are Dole™ Organic Romaine Hearts 3pk (UPC 0-71430-90061-1), combined English/French packaging, with Harvested-On dates of 10-23-20 and 10-26-20, and Wild Harvest Orga

Fresenius Kabi Issues Voluntary Nationwide Recall of a Single Lot of Dexmedetomidine Hydrochloride Injection Due to Cross-Contamination of Lidocaine
Thu, 19 Nov 2020 16:12:00 EST

  Fresenius Kabi USA is voluntarily recalling a single lot of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg /mL), 50 mL fill in a 50 mL vial. Fresenius Kabi initiated this recall due to a trace amount of lidocaine present in the lot. This recall is being performed to the

Fresh Express Recalls Limited Quantity of Expired Fresh Express Kit Caesar Supreme Due to Potential Health Risk
Tue, 17 Nov 2020 21:56:00 EST

  Fresh Express is voluntarily recalling a limited number of cases of expired 10.5 oz. Fresh Express Kit Caesar Supreme with the Use-by Date of November 8, 2020 and Product Code S296 because it may be contaminated with Escherichia coli STEC 026 bacteria. The recall is being executed out of an abundanc

Albright’s Raw Dog Food Recalls Chicken Recipe For Dogs Because of Possible Salmonella Health Risk
Fri, 13 Nov 2020 18:50:00 EST

  Albright’s Raw Dog Food of Fort Wayne, IN is voluntarily recalling 67 cases of Chicken Recipe for Dogs because it has the potential to be contaminated with Salmonella. Salmonella can affect animals eating the products and there is risk to humans from handling contaminated pet products, especially if

Kanan Enterprises Conducts Voluntary Recall of ALDI Southern Grove On the Go Sweet & Salty Trail Mix Due to Undeclared Almonds
Thu, 12 Nov 2020 15:48:00 EST

  Out of an abundance of caution Kanan Enterprises announces the voluntary recall of ALDI Southern Grove On the Go Sweet & Salty Trail Mix 8 Pack Caddies 1.5 oz., Best By JUL 27 2021 due to the presence of almonds that are not listed as ingredients. People who have an allergy to almonds run the risk

Lohxa LLC Issues Voluntary Nationwide Recall of Chlorhexidine Gluconate Oral Rinse USP, 0.12% Due to Microbial Contamination
Mon, 09 Nov 2020 14:10:00 EST

  Lohxa, LLC is voluntarily recalling Chlorhexidine Gluconate Oral Rinse USP, 0.12% Alcohol free (NDC:70166-027-15) products bearing an expiration date from 01/31/21 – 03/31/21 (see specific lots below) to the consumer level. This product is sourced and repackaged from Sunstar Americas Inc. who has no

Tanimura & Antle Voluntary Recalls Packaged Single Head Romaine Lettuce Due to Potential E. Coli 0157:H7 Contamination
Fri, 06 Nov 2020 00:00:00 EST

  Out of an abundance of caution, Tanimura & Antle Inc. is voluntarily recalling its packaged single head romaine lettuce under the Tanimura & Antle brand, labeled with a packed on date of 10/15/2020 or 10/16/2020, due to possible contamination with E. Coli 0157:H7. Packages contain a single head of r

Nostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit
Mon, 02 Nov 2020 15:33:00 EST

  Kansas City, Missouri, Nostrum Laboratories, Inc. is voluntarily recalling 2 (two) lots of Metformin HCl Extended Release Tablets, USP 750 mg to the consumer level. The Metformin HCl Extended Release Tablets, USP 750 mg have been found to contain levels of nitrosamine impurities above the ADI limit

Nostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 500 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit
Mon, 02 Nov 2020 00:00:00 EST

  Nostrum Laboratories, Inc. is voluntarily recalling 2 (two) lots of Metformin HCl Extended Release Tablets, USP 500 mg to the consumer level. The Metformin HCl Extended Release Tablets, USP 500 mg have been found to contain levels of nitrosamine impurities above the ADI limit of 96 ng/day as publish

Natural Grocers Issues Voluntary Recall on Organic Elderberries Due to Potential Presence of Salmonella
Thu, 29 Oct 2020 14:51:00 EDT

  Vitamin Cottage Natural Food Markets, Inc., a Lakewood, Colorado-based natural grocery retailer, is voluntarily recalling Natural Grocers Brand 4-ounce Organic Whole Elderberries after being notified by its supplier of the potential presence of Salmonella. Salmonella is an organism which can cause s

Baxter Issues Urgent Device Correction to Reinforce Important Safety Information Regarding Cleaning Practices of all Sigma Spectrum Infusion Pumps (V6, V8 and IQ)
Wed, 28 Oct 2020 10:19:00 EDT

  Baxter International Inc. announced today it has issued an Urgent Device Correction to reinforce important safety information regarding cleaning practices of all Spectrum infusion pumps distributed in the United States, Canada, and the Caribbean, as deviations from the specified cleaning methods may

Russ Davis Wholesale Issues Allergy Alert on Undeclared Egg in Mixed Veggie Cup With Dip
Wed, 28 Oct 2020 00:00:00 EDT

  Russ Davis Wholesale of Wadena, Minnesota is recalling individual serving cups of Mixed Veggie Cup with Dip because it may contain undeclared Egg. People who have an allergy or severe sensitivity to egg run the risk of serious or life-threatening allergic reaction if they consume these products.

Allergy Alert Issued for Undeclared Egg in Prepared Macaroni & Cheese Sold at Whole Foods Market Stores in Five States
Wed, 28 Oct 2020 00:00:00 EDT

  Whole Foods Market is voluntarily recalling select prepared Macaroni & Cheese products from stores across five states because they contain undeclared egg. People who have an allergy or severe sensitivity to egg run the risk of serious or life-threatening allergic reaction if they consume these produ

What's New: Drugs RSS Feed

What's New Related to Drugs
Mon, 30 Nov 2020 14:08:23 EST

  Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.

Generic Drug Facilities, Sites and Organization Lists
Mon, 30 Nov 2020 14:04:32 EST

  Generic Drug Facilities, Sites and Organization Lists

UPDATED PUBLIC PARTICIPATION INFORMATION: July 14, 2020: Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement - 07/14/2020 - 07/14/2020
Mon, 30 Nov 2020 14:00:29 EST

  July 14, 2020: Meeting of the Oncologic Drugs Advisory Committee Meeting Announcement

Why the United States-Mexico-Canada Agreement is Important to FDA
Mon, 30 Nov 2020 10:20:43 EST

  How the many provisions in the United States-Mexico-Canada Agreement affect FDA, advance public health and FDA’s regulatory approaches.

Human Drug Imports
Mon, 30 Nov 2020 09:41:22 EST

  Human drug import information including PLAIR, safe importation action plan, and personal importation policy.

Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program Submission Process
Mon, 30 Nov 2020 09:30:03 EST

  The 21st Century Cures Act formally established a multi-step process for Drug Development Tools (DDT) qualification. Qualification of a DDT is for a specific context of use (COU), and the qualified DDT may be used for the COU by any person in drug or biologics development.

Newly Added Guidance Documents
Mon, 30 Nov 2020 09:17:20 EST

  Guidance documents represent the FDA's current thinking on a particular subject. New guidance documents are listed here for three months.

Evaluation of Gastric pH-Dependent Drug Interactions With Acid-Reducing Agents: Study Design, Data Analysis, and Clinical Implications Guidance for Industry
Mon, 30 Nov 2020 09:11:25 EST

  Clinical Pharmacology
Evaluation of Gastric pH-Dependent Drug Interactions With Acid-Reducing Agents:
Study Design, Data Analysis, and Clinical Implications Guidance for Industry


Drug Development Tool (DDT) Qualification Programs
Mon, 30 Nov 2020 08:31:44 EST

  Information about the mission and objectives of FDA’s Drug Development Tool (DDT) qualification programs.

Novel Drug Approvals for 2020
Mon, 30 Nov 2020 08:31:36 EST

  The availability of new drugs and biological products often means new treatment options for patients and advances in health care for the American public

Drug Safety Oversight Board Meetings - Public Summaries
Mon, 30 Nov 2020 08:27:00 EST

  This page provides summaries of past DSB Meetings. Each summary include DSCs posted since the last meeting, topics presented and discussed with the Board. Views expressed by non-CDER employees are those of the individual and not necessarily the opinion of his/her respective federal agency or Inst.

Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program
Mon, 30 Nov 2020 08:08:10 EST

  The Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program is designed to expand DDT types by encouraging development of DDTs that are out of scope for existing DDT qualification programs but may still be beneficial for drug development.

User Fee Lists
Fri, 27 Nov 2020 15:38:40 EST

  Fiscal Year (FY) 2017 GDUFA facility fees are due on October 3, 2016.

FDA approves device for treatment of osteoid osteoma in the extremities
Fri, 27 Nov 2020 14:17:32 EST

  Hematology / Oncology News Burst

Drug Alerts and Statements
Fri, 27 Nov 2020 11:38:22 EST

  FDA Drug Alerts and Statements

Field Science - Laboratory Manual
Fri, 27 Nov 2020 10:09:45 EST

  The Laboratory Manual is a reference manual for FDA personnel. It provides FDA personnel with information on internal procedures to be used as an agency policy for testing consumer products, training of laboratory staff, report writing, safety, research, review of private laboratory reports and cour

Chapter 4 - Human Drugs - Sub Chapters 470- 490
Fri, 27 Nov 2020 10:09:43 EST

  Chapter 4 - Human Drugs - Sub Chapters 470- 490

Chapter 4 - Human Drugs
Fri, 27 Nov 2020 10:09:43 EST

  Chapter 4 - Human Drugs

Report Kids' Problems With Medical Products
Fri, 27 Nov 2020 09:39:55 EST

  Children's caregivers witness first-hand bad experiences with pediatric medical products or devices. FDA encourages consumers to report these experiences with drugs and device problems to the agency.

Some Medications and Driving Don't Mix
Fri, 27 Nov 2020 09:39:54 EST

  Some prescription and over-the-counter (OTC) medicines can cause reactions that may make it unsafe to drive

Whats New Vaccines Blood Biologics RSS Feed

What’s New for Biologics
Mon, 30 Nov 2020 11:12:35 EST

  Latest news from the Center for Biologics Evaluation and Research

Vaccines and Related Biological Products Advisory Committee December 10, 2020 Meeting Announcement - 12/10/2020 - 12/10/2020
Mon, 30 Nov 2020 11:03:25 EST

  This is the CBER Vaccines and Related Biological Products Advisory Committee December 10, 2020 Meeting Announcement.

Why the United States-Mexico-Canada Agreement is Important to FDA
Mon, 30 Nov 2020 10:20:43 EST

  How the many provisions in the United States-Mexico-Canada Agreement affect FDA, advance public health and FDA’s regulatory approaches.

Investigational COVID-19 Convalescent Plasma
Mon, 30 Nov 2020 09:53:48 EST

  FDA is issuing this guidance to provide recommendations to health care providers and investigators on the administration and study of investigational convalescent plasma collected from individuals who have recovered from COVID-19 (COVID-19 convalescent plasma) during the public health emergency.

Roster of the Allergenic Products Advisory Committee
Fri, 27 Nov 2020 14:37:39 EST

  As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

COVID-19 Vaccines
Fri, 27 Nov 2020 13:51:53 EST

  FDA has rigorous scientific and regulatory processes in place to facilitate development and ensure the safety, effectiveness and quality of COVID-19 vaccines.

Field Science - Laboratory Manual
Fri, 27 Nov 2020 10:09:45 EST

  The Laboratory Manual is a reference manual for FDA personnel. It provides FDA personnel with information on internal procedures to be used as an agency policy for testing consumer products, training of laboratory staff, report writing, safety, research, review of private laboratory reports and cour

Learn About FDA Patient Engagement
Wed, 25 Nov 2020 15:21:46 EST

  Learn about the different ways that patients and caregivers are working with the FDA to have their voice included in medical product approvals and FDA policy.

2020 Meeting Materials, Vaccines and Related Biological Products Advisory Committee
Wed, 25 Nov 2020 15:08:37 EST

  This is the main page for the CBER 2020 Meeting Materials, Vaccines and Related Biological Products Advisory Committee.

Recently Issued Guidance Documents
Wed, 25 Nov 2020 14:39:26 EST

  This page lists Recently Issued CBER and Cross-Center Guidance Documents.

Devices Guidances
Wed, 25 Nov 2020 14:38:15 EST

  This page lists Medical Device Guidance documents.

Developing a Toolkit to Assess Efficacy of Ebola Vaccines and Therapeutics
Wed, 25 Nov 2020 10:21:30 EST

  MCMi regulatory science project to research issues that are key to understanding and predicting if—and how—vaccines and therapeutics to prevent and treat Ebola will show efficacy

Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Announcement - 10/22/2020 - 10/22/2020
Wed, 25 Nov 2020 08:50:07 EST

  This is the CBER Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Announcement.

Safety and Effectiveness of Gene Therapy
Tue, 24 Nov 2020 16:53:34 EST

  A description of Andrew Byrnes' research program and related publications.

Impact of Immunity Induced by Viral and DNA Products
Tue, 24 Nov 2020 16:51:58 EST

  A description of Suzanne Epstein's research program and related publications.

FDA Patient Engagement Opportunities
Tue, 24 Nov 2020 15:56:33 EST

  A description of some of the opportunities for patients, caregivers and advocates to engage with the FDA.

Application Submissions Guidances
Tue, 24 Nov 2020 14:20:24 EST

  This page lists Application Submissions Guidance documents.

FDA Voices on Policy
Mon, 23 Nov 2020 14:51:38 EST

  FDA Voices on Policy

FDA Voices
Mon, 23 Nov 2020 14:49:25 EST

  Insights into the agency's work in the areas of medical products, food, tobacco, policy, consumer safety and enforcement.

Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccine Candidate
Fri, 20 Nov 2020 16:54:25 EST

  FDA has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10, 2020 to discuss Pfizer and BioNTech’s emergency use authorization request for a COVID-19 vaccine.







 
 

Contact Us


Corporate Headquarters


Practical Compliance Solutions
One Orient Way - Suite F156
Rutherford, NJ 07070
Phone: 201-728-8809


40.827731 N 74.101029 W

Connect With Us

   
 
 
© 2002 - 2020 - Copyright Practical Compliance Solutions - All rights reserved